subject: Stem Cell Research - Market Trends, Investment Trends And Pipeline Analysis-aarkstore Enterprise Mar [print this page] Summary Summary
The leading business intelligence provider, has released its latest research Stem Cell Research - Market Trends, Investment Trends and Pipeline Analysis. It is an essential source of information and analysis on global stem cell research and development. This pharmaceutical and healthcare report identifies the key trends shaping and driving stem cell research and development. The report analyses investment decisions within the stem cell research market by providing information on pipelines, federal spending, investor perspectives, regulatory environment, competitive landscape and market potential. The study also provides insight on the prevalent competitive landscape and the emerging players expected to significantly shift the market positioning. Most importantly, the report provides valuable insight on the pipeline products within the global stem cell industry.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Researchs team of industry experts.
Scope
The scope of this report includes:
- Unmet needs and opportunity analysis for therapies that are currently in pipeline.
- Market characterization including market sizing, technology adoption framework and business models for the stem cell market.
- A cross-country analysis for regulatory framework, investments, research clusters and support including the US (United States), the UK (United Kingdom), Germany, France, Japan, China, India, Singapore, Canada and Australia
- In-depth information and analysis on the pipeline products expected to bring a shift in the market positions of the leading manufacturers.
- Analysis and review of the key events and milestones that will impact the future of the global stem cell market. Each trend independently researched to provide qualitative analysis of what the implications on sectors are, and how companies are responding to these trends.
- Insightful review of key industry drivers, restraints and challenges which are likely to impact the global stem cell research and development in the long run.
- Information on the leading market players and the prevailing competitive landscape. Key companies covered include Osiris Therapeutics, Aastrom Biosciences, Cytori Therapeutics, Pluristem Therapeutics and Geron.
